Basic Principles of Pharm (Exam 1) Flashcards
Define Pharmacology and all that it entails (3)
- Study of chemical interactions with living systems (endogenous or exogenous)
- Medical: Prevent, diagnose, and treat disease
- *Toxicology *(posions/toxins): undesirable efffect of chemicals on living systems
toxins are biological vs poisons
Explain the History of Pharmacology until today
Notable times and peoples
Prehistoric, ancient egypt, ayurvedic, ancient greek, traditional chinese.
Materia Medica (greek): collection of text throughout history; precursor to pharmacology (botany and medicinal)
Pracelsus 1493-1541: Father of toxicology “Dose makes the poison”
Modern Pharm: Utilizes scientific principles and clinical testing
Anesthetic Pharm: 1. science of drug 2. Practical knowledge
Imhotep ancient egypt
Hippocrates father of western medicine
Dioscorides Materia Medica
Identify and define the branches of Pharmacology (4)
- Pharmacodynamics: what the drug does to the body
- Pharmokinetics: what the body does to the drug (ex: 1/2 life, breakdown, etc.)
- Pharmocogenetics: genetic profile response to a drug (ex. BrCx)
- Toxicology: undesirable efffect of chemicals on living systems
Define an agonist and what it does
a substance that ellicits a response (activator) targeting a receptor
ex. epi, NE
endogenous ligands are small molecules the body produces such as Epi
vs exogenous ligands are synthetic made outside of the body
Define an antagonist and what it does
a substance that blocks/shutdowns (inhibits) a receptor
ex. BB
What is a receptor and what types are there
Typically a protein and binding site for a drug
Endogenous: within the body
Exogenous: outside the body
Identify the difference between poisons and toxins
poisons are non-biologic and toxins are biologic
ex. of toxin: mushroom, pufferfish
Identify the physical nature of drugs (4)
Solid, liquid, or gas
organic: carb, lipid, protein
inorganic: metals
drug size 100-1000 MW or Da
drug size is important for transport
Identify the properties of receptor interactions
lock and key mechanism
dependent on size charge, shape and atomic composition
What are the three main bond types and relative strength and specificity
(strongest) covalent: (less specific)
(middle) electrostatic: charged, h-bonds, Van der Walls (medium specificity)
(weakest) hydrophobic: lipid soluble (very specific)
What is stereoisomerism (chirality) and its effects on drugs
Optical isomers (enantiomers) that mirror eachother but cannot be superimposed affect how drug fits in the receptor. can affect the metabolism of the drug
one isomer may be more portent and the other toxic
(D:L;R:S) Left and Right hand
What are racemic mixtures and give an example
Drug that contains both stereoisomers
ex. Ketamins (R) and (S)
(R) more roxic (S) more potent
Compare orthosteric vs alloteric interactions
Orthosteric binds to the active site of the receptor
Allosteric binds to another site; not the active site
Compare specific vs non-specific interactions
specific requires less drug concentration compared to non-specific to have the same maximum effect
What are the three drug-receptor interactions and what do they do
Agonist: Drug binds to receptor and response
Anatagonist: bind to receptor and no response
Allosteric non-competitive: activators and inhibitors
Define Bmax, Kd, EC50, Emax and explain their relationship to eachother
Bmax: maximum binding to receptor
Kd: drug concentrion 1/2 receptors bound
Emax: Maximum effect
EC50: 50% effect
decrease Kd= high affinity
increase Kd=low affintiy
decrease EC50= less drug concentration
increase EC 50= more drug concentration
EC 50 (potency) vs Kd (efficacy)
Explain how agonists, competitive inhibitors, allosteric activators, and allosteric inhibitors affect drug response curve
agonisits and allosteric: decrease dose and exponentially increase response
agonists: steady response and drug dose
agonists and competitive inhib: increase dose (EC50) to reach Emax
agonist and allosteric inhibitor: minimal response despite increased dose
Explain how indirect agonist/agonist mimic work
Agonists cause a downstream effect and goes from A->C, an enzyme can be activated to reduce the breakdown of C increasing it and its effect
Explain the receptor-antagonist interaction of competitive inhibitors
they bind and inhibit a response can be countered by increasing the amount of agonists (surmountable)
E50 increased; Emax the same
Explain the receptor-antagonist interaction of non-competitive inhibitors
non-competitive is insurmountable (irreversible) EC50 same; decreases Emax
orthosteric covalent binding is insurmountable
it forms a covalent bond and agonists cannot bind to active site
Explain the receptor-antagonist interaction of partial agonists
full response is not seen only partial (decreased Emax)
not related to affinity and can block full agonist binding acting as an antagonist
Name other mechanisms of antagonism (2)
Opposite charges
Physiologic antagonism such as fight and flight response vs rest and digest
adminster + charge drug to bind to - charge inhibiting effects
physiologic antagonism: Epi increase HR and ACh decreases HR
How do receptor configurations affect drug response
R’i equilibrium with R’a
Agonists shift the equilibrium to R’a
Anatgonists equilibrium does not change
Inverse Agonsits shift the equilibrium to R’i
i- inactive form a- active form
inverse agonists remains in inactive form making it an antagonists
Compare the drug response curve in relation to R’a and R’i with agonists, partial agonists, antagonist, inverse agonists
Full agonists: max response
Partial agonists: decreased response
Antagnoists: baseline response
Inverse agonist: no response
Give examples of B-1 Receptor drugs agonist (direct & indirect), parital agonist, antagonist, and inverse agonist
agonist(direct): Epi, NE
agonist(indirect): amphetamine, cocaine
partial agoinist: pindolol, acebutolol
antagonist: propanolol, atenolol
inverse: carvedilol, nadolol
Pharmacodynamics
what are the three concepts of duration of action
- how long the drug binds to the receptor
- long term downstream effects used up and signaling shutdowns (can be associated with the receptor or effects of the receptor) and covalent bond receptor is degraded
- densenitization: when the drug is bound to the receptor the cell still shutsdown/dampens the signal process ; protective (GPCR)